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Abstract
The infantile subglottic hemangioma can be treated in various ways. The results of the
treatment used in the Sophia Children’s Hospital, intralesional steroids and intubation
(ISI), are discussed and compared with the results of other current treatment methods:
CO2 laser vaporization, submucous resection and intubation alone. A total of 18 infants were
treated for subglottic hemangioma in our hospital: ten with ISI alone, five were first
treated with systemic therapy and later with ISI alone and three with various therapies.
ISI was effective in 14 of the 15 patients, one patient was lost from follow up. The
remaining three infants were treated with (combinations of) various therapies, because ISI
failed or was not tried. Two patients were finally cured, one still has a tracheotomy. Of other
current therapies, CO2 laser vaporization is reported to be effective. In all 30% of the infants
treated in Boston Children’s Hospital with CO2 laser needed a tracheotomy. Moreover
subglottic stenosis is a serious complication. Submucous resection is often successful. It may
be complicated by subglottic stenosis and in some cases, depending on the localization of the
hemangioma, it may be contraindicated. Intubation alone is less effective than intubation
combined with intralesional steroids. Management of subglottic hemangioma in Sophia
Children’s Hospital is primarily intralesional steroids and intubation and secondarily submu-
cous resection or tracheotomy. CO2 laser vaporization is seldom applied because of the risk
of subglottic stenosis. © 1997 Published by Elsevier Science Ireland Ltd.
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1. Introduction
A subglottic hemangioma is a benign tumor which spontaneously goes into
regression during infancy. It usually presents with symptoms of respiratory tract
obstruction in the first months of life. The male to female ratio is reported to be 1:2
[2,22]. Histologically, most hemangiomas are capillary (91.6%), the others are
cavernous or mixed [21]. The diagnosis is made on the endoscopic appearance of
the tumor and may be confirmed by biopsy. Most hemangiomas are confined to the
subglottis, extralaryngeal extension will be revealed by magnetic resonance imaging.
A great variety of therapies and, in many instances combinations of therapies,
have been applied: ‘wait and see’ with or without tracheotomy [6,18] systemic
steroids [4,10] interferon [16,23], short-term intubation [15], CO2 (or other) laser
[11,22], open surgical approach and submucous resection [7,14,17,20,19,24], intrale-
sional steroids with short-term intubation, developed in the Sophia Children’s
Hospital [13] and other therapies [1].
‘Wait and see’ can only be employed for hemangiomas with minor symptoms. A
tracheotomy does not influence the natural course of the hemangioma and thus has
to remain in place possibly for several years. Moreover a tracheotomy has consid-
erable consequences for general and speech development, is associated with respira-
tory tract infections and has a mortality rate of 1–2% [8]. Systemic steroids have a
(limited) effect on the airway obstruction and, if given for a long period, serious
side effects: growth retardation, Cushing syndrome and immune deficiency. Their
value lies in their use as an additional therapy. Interferon has reportedly a beneficial
effect, but its working mechanism and indications are yet to be defined.
The more effective or established therapies are CO2 laser vaporization, submu-
cous resection, short-term intubation and intralesional steroids followed by short-
term intubation.
The present report aims to evaluate the method used in the Sophia Children’s
Hospital, intralesional steroids and intubation and to compare this method with
three current therapies employed in other institutions: CO2 laser, resection and
intubation. Finally a therapeutic approach of the subglottic hemangioma is formu-
lated, based upon our results and the findings reported in the literature.
2. Patients and methods
The records of all patients treated for subglottic hemangioma in the Sophia
Children’s Hospital from 1982 to 1997 were studied retrospectively. The treatment
policy during that period included in most patients intralesional injection of
steroids, followed by one week intubation (ISI). Treatment was only employed if
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serious symptoms of airway obstruction were present. Approximately 60 mg
methylprednisolone was administered into the lesion, a spillage of a few mg was
usually unavoidable. The treatment was repeated when symptoms of severe obstruc-
tion recurred. If that happened within 4 weeks, the patients were intubated but they
received no steroids to avoid overdose. The treatment method was extensively
described in an earlier report [13].
In all, 18 infants (13 girls and five boys) with subglottic hemangioma were treated
in our hospital, either primarily or after treatment elsewhere and referral. The age
at first manifestation of the symptoms, the localization and size of the tumor and
its treatment are presented in Table 1. Criteria for the diagnosis were the endo-
scopic aspect, localization and firmness of the tumor. Biopsies were obtained only
in a minority of the cases. The percentage of obstruction was visually estimated on
endoscopy. Approximately half of the infants also had cutaneous hemangioma.
A total of ten patients were treated with ISI alone. Some five others were first
treated elsewhere with systemic steroids or interferon, but were referred to our
hospital when signs of airway obstruction recurred. Systemic treatment was discon-
tinued and replaced by ISI. Another patient was treated with ISI, systemic
steroids, laser surgery and finally a tracheotomy. There was one patient that had
ISI, laser surgery and finally a laryngofissure and submucosal resection of the
hemangioma. An infant underwent a tracheotomy followed by submucous resection
for a subglottic stenosis. The tissue responsible for the stenosis was resected and
appeared to be a hemangioma at histologic examination.
Treatment was called a success if from the moment of its termination no serious
symptoms of obstruction (re)occurred.
The results of ISI in Sophia Children’s Hospital are compared to the results of
various therapies reported from other hospitals.
3. Results
The results of the therapies employed in the Sophia Children’s Hospital are
shown in Table 2. An unobstructed airway was achieved in all ten patients treated
Table 2
Treatment results in Sophia Children’s Hospital; ISI only and various therapies in combination with
ISI
Mean follow up (years)Treatment Mean age when curedN curedN
(months)
10ISI 8 (9:12–13)10 8 (4–14)
13 (6–20)5 5 (2–10); (no follow up in 1)4SS; (Interf); ISI
0 — TracheotomyISI; SS; laser; trach. 1
2ISI; laser; resection 1 1 14
61 15Trach; resection 1
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Table 3
Treatment in Sophia Children’s Hospital; ISI in 14 cured patients and in three patients in which
ISI was without success
Not cured (3)Cured (14)
3 (1–12) 5 (2–11)Number of injections
8 (3–16)6 (1–20)Number endoscopies and intubations
37 (6–129)Days intubated 54 (20–93)
5 (1–12)Duration of treatment (months) 5 (1–9)
9.5 (4–20) 11 (8–14)Age at last treatment (months)
with ISI only, at ages between 4 and 14 months (mean 8 months). Four of five
patients in whom the systemic treatment was replaced by ISI, had a patent
airway at ages between 6 and 20 (mean 13) months. The remaining patient went for
further treatment elsewhere and was lost from follow up.
ISI was unsuccessful in two infants. One was given a tracheotomy at 14
months, the other was successfully treated with a submucous resection at 12 months
of age. The policy of ISI was effective in 14 of 17 patients (82%).
Systemic side effects of intralesionally administered steroids such as growth
retardation or Cushing syndrome were not seen. Some infants showed laryngeal
granulations, or suffered from lower airway infections during the intubation. None
of the patients developed subglottic stenosis.
Table 3 shows what ISI involved for the patients in terms of number of
injections, intubations and duration of therapy. A mean number of six endoscopies
in general anesthesia followed by six periods (37 days) of intubation were needed in
the infants treated with success. After a treatment period which lasted a mean 5
months (range 1–12), a permanently patent airway was achieved at a mean age of
9.5 months (range 4–20).
The follow up periods vary between 9 months and more than 13 years. One
patient is still dependent on a tracheotomy at 3 years of age, a second was lost from
follow up. All others have an unobstructed airway and develop normally.
4. Discussion
The natural course of an infantile cutaneous hemangioma consists of rapid
growth during the first year of life, followed by a slow involution that may last 5–7
years [3,9,25]. The study of the natural course of a subglottic hemangioma is
impeded by the need for intervention, but most authors agree that it shows a
similarly rapid growth until 6–12 months of age [12,15], followed by involution
after 18 or more months [6,15,19]. Patients treated by Sebastian with a tracheotomy
only, could be decannulated at an average age of 17 months [18].
Consequently, treatment of subglottic hemangioma should aim, first at maintain-
ing a patent airway during the first years of life and second, if possible, at
shortening the natural course of the tumor. Therapies that may involve serious side
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effects, such as subglottic stenosis, or delay in speech and general development,
should possibly be avoided.
A total of four established therapies are compared for their efficacy and side
effects: CO2 laser vaporization, submucous resection, short-term intubation and
intralesional steroids followed by intubation. The results are shown in Table 4.
In all 28 infants treated for subglottic hemangioma with CO2 laser vaporization
at the Boston Children’s Hospital, a patent airway was achieved by 3 years of age
or earlier. Besides CO2 laser treatment most patients also received systemic steroids.
Five patients were referred with a tracheotomy and seven (30%) more of the
remaining 23 infants needed one during the treatment. Subglottic stenosis compli-
cated the treatment in five infants (18%) [22]. CO2 laser treatment, although
effective, appears to have a high risk for stenosis [5] and in many patients a
tracheotomy cannot be avoided.
Submucous resection has been successful in several reported cases. A tra-
cheotomy may be avoided or is only needed for a short period. A subglottic stenosis
following a resection was reported by Wiatrak [24]. Extension into the glottis or
deep into the trachea are relative contraindications [7,14,17,19,20,24].
The treatment reported by Narcy, intubation for 10 days after systemic steroids
had failed, cured ten of 16 patients (63%). Of these 16 infants four needed a
tracheotomy [15]. Intubation alone appears less effective than intubation plus
intralesional steroids.
The treatment of first choice in the Sophia Children’s Hospital, intralesional
steroids and short-term intubation, achieved in 82% of the patients a permanently
patent airway at a mean 9.5 months of age. With this approach only one infant
(6%), in which ISI failed, needed a long-term tracheotomy and subglottic
stenosis did not occur. The side effects were limited: respiratory tract infections
caused by the intubation and repeated hospitalizations. Some infants had many
endoscopies and were intubated for a rather long total period.
Table 4
Comparison of four current treatment methods in various institutions: CO2 laser [22] resection [24],
intubation [15], ISI [this report]
Patients (%) with aTracheotomy necessary Treatment
during treatment (%) complicated by patent airway
stenosis (%)
CO2 laser (n28) 1830 100 at B3 years.
Resection (n19) 553 95 at 10 months. (mean)
Intubation (n16) 25 6 63 at 91 year
0ISI (n18) 82 at 9.5 months. (mean)6
Criteria: tracheotomy necessary during treatment, treatment complicated by stenosis and age when
patent airway.
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5. Conclusion
Management of infantile subglottic hemangioma in our hospital implies intrale-
sional steroids followed by intubation. Contrary to former years now the number of
intubation periods are usually limited to two or three. The second choice treatment
is submucous resection, or if that operation is contra-indicated, a tracheotomy.
Systemic steroids (and maybe interferon in future) can be used as an additional
therapy for short periods. We seldom apply CO2 laser vaporization, as the risk for
subglottic stenosis is considered too high.
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